Helvetica Chimica Acta Vol. 87 (2004)
2187
(d, C(25)); 120.9 (d, C(16)); 119.0 (d, C(24)); 115.6 (d, C(26)); 114.5 (d, C(22)); 114.1 (d, C(12)); 83.3 (s, C(14)).
APCI-MS (acetone): 347 (22, [M Cl]À), 311 (50, [M À H]À). HR-MS: 311.9656 (M , C12H9O2I ; calc.
311.9647).
2,2'-[(4-Iodo[1,1'-biphenyl]-3,3'-diyl)bis(oxy)]bis[acetic Acid] Dibenzyl Ester (14). To a soln. of 13
(120 mg, 0.39 mmol) in dry acetone (25 ml) was added Cs2CO3 (757 mg, 2.34 mmol). The resulting suspension
was stirred at r.t. for 10 min. Then benzyl bromoacetate (182 ml, 1.17 mmol) was added, and the suspension was
stirred for an additional hour. The mixture was evaporated, the residue dissolved in AcOEt, the soln. washed
with brine, dried (MgSO4), and evaporated and the crude product purified by CC (CH2Cl2/petroleum ether 4 :1,
then CH2Cl2): anal. pure 14 (206 mg, 87%). Colorless solid. TLC (CH2Cl2): Rf 0.53. M.p. 89 908. IR: 3035w,
2914w, 1716s, 1593m, 1561m, 1474m, 1455m, 1395m, 1233s, 1071s, 968m. 1H-NMR (300 MHz, CD2Cl2): 7.86
(d, 3J 8.1, HÀC(15)); 7.42 7.30 (m, 2 PhCH2, HÀC(25)); 7.13 (ddd, 3J 7.7, 4J 1.5, 1.5, HÀC(26)); 7.07
(dd, 4J 1.9, 1.5, HÀC(22)); 6.96 (dd, 3J 8.1, 4J 1.9, HÀC(16)); 6.91 (d, 4J 1.9, HÀC(12)); 6.90 (ddd, 3J 7.7,
4J 1.5, 1.5, HÀC(24)); 5.25 (s, PhCH2 (ring 1)); 5.24 (s, PhCH2 (ring 2)); 4.81 (s, CH2OÀC(13)); 4.74
(s, CH2OÀC(23)). 13C-NMR (75 MHz, CD2Cl2): 168.9 (s, COCH2OÀC(23)); 168.4 (s, COCH2OÀC(13)); 158.6
(d, C(23)); 157.3 (d, C(13)); 142.9 (s, C(11)); 142.0 (s, C(21)); 140.4 (d, C(15)); 135.8 (s, 2 Cipso (Bn)); 130.4
(d, C(25)); 129.0 128.6 (6d, 4 Co, 4 Cm, 2 Cp (all Bn)); 122.7 (d, C(16)); 120.8 (d, C(26)); 114.0 (d, C(22)); 114.0
(d, C(24)); 111.6 (d, C(12)); 85.5 (s, C(14)); 67.4 (t, 2 PhCH2); 66.7 (t, CH2OÀC(13)); 65.8 (t, CH2OÀC(23)).
APCI-MS (acetone; neg.): 643 (5, [M Cl]À), 517 (24, [M À I Cl]À), 459 (100, [M À 2 Bn Cl]À). APCI-MS
(acetone; pos.): 608 (12, [M] ), 482 (100, [M À I] ), 391 (47, [M À Bn À I] ). HR-MS: 608.0739 (M ,
C30H25O6I ; calc. 608.0696).
{424}-p-Octiphenyl 1 (2,2',2'',2''',2'''',2''''',2'''''',2'''''''-[[1,1':4',1'':4'',1''':4''',1'''':4'''',1'''''.4''''',1'''''':4'''''',1'''''''-
Octiphenyl-2'',2'''',2'''''',3,3',3''',3''''',3'''''''-octayloctakis(oxy)]octakis[acetic Acid] 01,01',01'''''',01'''''''-Tetrabenzyl
01'',01''',01'''',01'''''-Tetra(tert-butyl) Ester). To a soln. of 14 (300 mg, 0.49 mmol) in degassed MeCN (9 ml) were
added [PdCl2(dppf)] (3 mol-%), Et3N (412 ml, 3.0 mmol) and 4,4,5,5-tetramethyl-1,3,2-dioxaborolane
( pinacolborane) (430 ml, 3.0 mmol). The soln. was heated at 808 for 3 h. Benzene (8 ml) was then added
and the soln. washed with brine, dried (MgSO4), and evaporated: intermediate 12.
a) Crude 12 (68 mg, 0.11 mmol) was then added to a soln. of 11 (20 mg, 0.019 mmol), [Pd(PPh3)4] (6 mol-
%) and K2CO3 (15 mg, 0.11 mmol) in degassed DMSO (3 ml). The soln. was heated at 908 for 14 h. After
cooling to r.t., CHCl3 (40 ml) was added, the mixture washed with H2O, dried (MgSO4), and evaporated, and the
crude product purified by prep. TLC (CH2Cl2/AcOEt 120 :1, double elution): anal. pure 1 (17 mg, 51%).
Colorless solid.
b) Crude 12 (68 mg, 0.11 mmol) was added to a soln. of 11 (20 mg, 0.019 mmol), [Pd(PPh3)4] (6 mol-%),
and CsF (17 mg, 0.11 mmol) in degassed THF (3 ml). The soln. was heated to reflux for 14 h. Workup and
purification as in a) gave anal. pure 1 (13.5 mg, 44%). Colorless solid. TLC (CH2Cl2/AcOEt 120 :1): Rf 0.27.
1H-NMR (500 MHz, CD2Cl2): 7.52 (d, 3J 7.9, HÀC(45), HÀC(56)); 7.47 (d, 3J 7.7, H ÀC(25), HÀC(76)); 7.46
(d, 3J 7.1, H ÀC(36), HÀC(65)); 7.38 (m, HÀC(15), HÀC(85)); 7.36 (m, 4 Ho (Bn, rings 1 and 8), 4 Hm (Bn,
rings 1 and 8)); 7.35 (m, 2 Hp (Bn, rings 1 and (8));7.34 (m, HÀC(46), HÀC(55)); 7.33 (m, HÀC(35), HÀC(66));
7.31 (m, 4 Ho (Bn, rings 2 and 7)); 7.30 (m, 2 Hp (Bn, rings 2 and 7), 4 Hm (Bn, rings 2 and 7)); 7.29 (dd, 3J 7.7,
4J 1.6, HÀC(26), HÀC(76)); 7.23 (ddd, 3J 7.7, 4J 1.7, 0.8, HÀC(16), HÀC(86)); 7.16 (dd, 4J 2.5, 1.7,
HÀC(12), HÀC(82)); 7.14 (d, 4J 1.6, HÀC(42), HÀC(53)); 7.09 (d, 4J 1.7, HÀC(33), HÀC(62)); 7.09 (d, 4J
4
1.6, HÀC(22), HÀC(73)); 6.91 (ddd, 3J 8.2, J 2.5, 0.8, HÀC(14), HÀC(84)); 5.25 (s, 2 PhCH2 (rings 1 and
8)); 5.20 (s, 2 PhCH2 (rings
2
and 7)); 4.77 (s, CH2OÀC(23), CH2OÀC(72)); 4.76 (s, CH2OÀC(13),
CH2OÀC(82); 4.62 (s, CH2OÀC(43), CH2OÀC(52)); 4.56 (s, CH2OÀC(32), CH2OÀC(63)); 1.49 (s, 2 tBu (rings
4
and 5)); 1.47 (s, 2 tBu (rings
3
and 6)). 13C-NMR (125 MHz, CD3OD): 169.2 (s, COCH2ÀC(23),
COCH2ÀC(72)); 169.0 (s, COCH2ÀC(13), COCH2ÀC(83)); 168.2 (s, COCH2ÀC(43), COCH2ÀC(83)); 168.2
(s, COCH2ÀC(32), COCH2ÀC(63)); 158.7 (s, C(13), C(83); 156.3 (s, C(43), C(52)); 156.2 (s, C(32), C(63)); 156.2
(s, C(23), C(72)); 142.9 (s, C(11), C(81)); 142.1 (s, C(34), C(61)); 142.0 (s, C(41), C(54)); 141.9 (s, C(21), C(74));
135.9 (s, 4 Cipso (Bn, rings 1, 2, 7 and 8)); 132.7 (d, C(25), C(76)); 132.6 (d, C(45), C(56)); 132.5 (d, C(36), C(65));
130.4 (d, C(15), C(85)); 129.0 (d, 4 Cm (Bn, rings 1 and 8)); 129.0 (d, 4 Cm (Bn, rings 2 and 7)); 128.9 (d, 2 Cp (Bn,
rings 1 and 8)); 128.8 (d, 2 Cp (Bn, rings 2 and 7)); 128.7 (d, 4 Co (Bn, rings 1 and 8)); 128.7 (d, 4 Co (Bn, rings 2
and 7)); 127.3 (s, C(24), C(71)); 127.1 (s, C(44), C(51)); 126.9 (s, C(31), C(64)); 121.0 (d, C(16), C(86)); 120.7
(d, C(26), C(75)); 120.4 (d, C(46), C(55)); 120.4 (d, C(35), C(66)); 114.0 (d, C(12), C(82)); 113.8 (d, C(14), C(84));
111.6 (d, C(22), C(73)); 111.4 (d, C(42), C(53)); 111.3 (d, C(33), C(52)); 82.4 (s, 4 Me3C (rings 3 5)); 67.3
(t, 2 PhCH2 (rings 1 and 8)); 67.2 (t, 2 PhCH2 (rings 2 and 6)); 66.7 (t, CH2OÀC(43), CH2OÀC(52)); 66.6
(t, CH2OÀC(32), CH2OÀC(63)); 66.5 (t, CH2OÀC(23), CH2OÀC(72)); 65.9 (t, CH2OÀC(13), CH2OÀC(83));